4 Reasons Teladoc Health Stock Can Reach $305
Shares of Teladoc Health (NYSE: TDOC) have more than doubled in 2020 and analysts tasked with watching the telehealth pioneer are confidently predicting more gains ahead. Ahead of Teladoc's third-quarter earnings call, Sean Wieland at Piper Sandler raised his price target for Teladoc to $305, a 42% gain over the stock's recent price.
Teladoc Health stock dipped during Thursday's trading session despite a positive vote to join forces with Livongo Health (NASDAQ: LVGO). Here are four of the biggest reasons investors can be confident about Teladoc's ability to make the Livongo deal work for investors and surpass lofty analyst expectations.
Source Fool.com
